This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| COVID-19 | 2001 |
| SARS | 950 |
| CoV-2 | 716 |
| CT | 355 |
| China | 350 |
| PCR | 236 |
| RT | 232 |
| Wuhan | 222 |
| PPE | 213 |
| mg | 198 |
| Health | 198 |
| ARDS | 175 |
| Coronavirus | 167 |
| Cureus | 152 |
| DOI | 142 |
| sha | 137 |
| ICMJE | 134 |
| United | 124 |
| March | 120 |
| States | 113 |
| IV | 112 |
| Disease | 111 |
| ACE2 | 108 |
| World | 102 |
| Pakistan | 101 |
| Table | 100 |
| April | 100 |
| US | 97 |
| ICU | 96 |
| L | 91 |
| Organization | 86 |
| Consent | 86 |
| CoV | 82 |
| RNA | 81 |
| Gy | 79 |
| MERS | 76 |
| ED | 75 |
| ADHD | 71 |
| HCQ | 70 |
| December | 69 |
| HCP | 64 |
| May | 60 |
| EM | 59 |
| U.S. | 58 |
| Hospital | 57 |
| C | 57 |
| COVID | 56 |
| Nepal | 55 |
| DKA | 55 |
| CRP | 55 |
| LOS | 54 |
| February | 54 |
| East | 53 |
| CDC | 53 |
| Italy | 52 |
| N95 | 52 |
| ECMO | 51 |
| India | 49 |
| remdesivir | 48 |
| azithromycin | 48 |
| University | 48 |
| T | 48 |
| January | 48 |
| SLT | 46 |
| MRI | 45 |
| IE | 45 |
| HRP | 45 |
| GGO | 45 |
| CCB | 44 |
| Middle | 43 |
| Medical | 43 |
| National | 41 |
| II | 41 |
| Review | 40 |
| Control | 40 |
| CSF | 40 |
| AKI | 40 |
| < | 39 |
| Figure | 38 |
| hydroxychloroquine | 37 |
| American | 37 |
| GI | 35 |
| ng | 34 |
| CDT | 34 |
| BVM | 34 |
| New | 34 |
| meta | 33 |
| LDH | 33 |
| U | 32 |
| HIV | 32 |
| F | 31 |
| A | 31 |
| CNS | 31 |
| Center | 31 |
| Committee | 31 |
| FFRCT | 31 |
| June | 31 |
| Prevention | 31 |
| Staphylococcus | 31 |
| WBC | 31 |
| WHO | 30 |
| VL | 30 |
| Society | 30 |
| SBCYOR | 30 |
| HCWs | 30 |
| Care | 30 |
| CCTA | 29 |
| Healthcare | 29 |
| Association | 29 |
| Epub | 29 |
| HLH | 29 |
| Holy | 29 |
| IBM | 29 |
| IL-6 | 29 |
| USA | 29 |
| mL | 29 |
| stridor | 28 |
| ST | 28 |
| ECG | 28 |
| Covid-19 | 28 |
| Use | 27 |
| PubMed | 27 |
| Island | 27 |
| DL | 27 |
| CDA | 27 |
| IMG | 26 |
| Centers | 26 |
| SBRT | 26 |
| PE | 26 |
| York | 25 |
| Virtual | 25 |
| Rhode | 25 |
| Patient | 25 |
| Communion | 25 |
| CXR | 25 |
| HCoV | 24 |
| America | 24 |
| Clinical | 24 |
| College | 24 |
| GIS | 24 |
| OUD | 24 |
| Hydroxychloroquine | 24 |
| S | 24 |
| Research | 24 |
| Lancet | 24 |
| Karachi | 23 |
| Japan | 23 |
| EKG | 23 |
| Department | 23 |
| CVD | 23 |
| IV+US | 22 |
| Arabia | 22 |
| CD8 | 22 |
| California | 22 |
| Saudi | 22 |
| PCT | 22 |
| Pandemic | 22 |
| Study | 22 |
| lymphopenia | 22 |
| Legionnaires | 21 |
| Candida | 21 |
| Conversation | 21 |
| Infectious | 21 |
| Board | 21 |
| Medicine | 21 |
| South | 21 |
| mmol | 21 |
| tocilizumab | 21 |
| Sciences | 21 |
| Hubei | 20 |
| AMI | 20 |
| Case | 20 |
| DIC | 20 |
| FDA | 20 |
| Germany | 20 |
| Institutional | 20 |
| K | 20 |
| M | 20 |
| Management | 20 |
| NY | 20 |
| SPSS | 20 |
| Fusobacterium | 19 |
| AVAPS | 19 |
| Assessment | 19 |
| Cancer | 19 |
| Treatment | 19 |
| L. | 19 |
| MI | 19 |
| TMPRSS2 | 19 |
| Armonk | 18 |
| COPD | 18 |
| Chronic | 18 |
| Emergency | 18 |
| IRB | 18 |
| Likert | 18 |
| Institute | 18 |
| International | 18 |
| July | 18 |
| Spain | 18 |
| MRSA | 18 |
| Novel | 18 |
| Scale | 18 |
| TnT | 18 |
| VSR | 18 |
| ageusia | 18 |
| mm | 18 |
| ritonavir | 18 |
| Ministry | 18 |
| Dr. | 17 |
| ACE-2 | 17 |
| CAD | 17 |
| CD4 | 17 |
| CE | 17 |
| City | 17 |
| Kawasaki | 17 |
| ER | 17 |
| NT | 17 |
| STEMI | 17 |
| VV | 17 |
| hs | 17 |
| Equipment | 16 |
| Brazil | 16 |
| Diseases | 16 |
| ESRD | 16 |
| Ebola | 16 |
| Europe | 16 |
| KD | 16 |
| Lebanon | 16 |
| OSA | 16 |
| PH | 16 |
| 16 | |
| microbleeds | 16 |
| B | 15 |
| Kingdom | 15 |
| Acute | 15 |
| CMBs | 15 |
| DVT | 15 |
| France | 15 |
| GBS | 15 |
| H1N1 | 15 |
| Iran | 15 |
| Korea | 15 |
| interleukin-6 | 15 |
| tigecycline | 15 |
| lopinavir | 15 |
| kg | 15 |
| piperacillin | 15 |
| TTE | 15 |
| San | 15 |
| Remdesivir | 15 |
| HFNC | 14 |
| Analysis | 14 |
| Asia | 14 |
| BP | 14 |
| Chest | 14 |
| DM | 14 |
| Evaluation | 14 |
| Guillain | 14 |
| disease | 14 |
| JAMA | 14 |
| NCCN | 14 |
| OC43 | 14 |
| PCP | 14 |
| SIADH | 14 |
| Syndrome | 14 |
| multiorgan | 14 |
| EBV | 13 |
| CK | 13 |
| D | 13 |
| COV-2 | 13 |
| CORD | 13 |
| Human | 13 |
| August | 13 |
| ASC | 13 |
| ALT | 13 |
| Greece | 13 |
| EEG | 13 |
| Pacific | 13 |
| Hong | 13 |
| IU | 13 |
| IgG | 13 |
| Kong | 13 |
| UK | 13 |
| Protective | 13 |
| Public | 13 |
| SE | 13 |
| SS | 13 |
| School | 13 |
| Chinese | 12 |
| Delhi | 12 |
| Cov-2 | 12 |
| County | 12 |
| Corp. | 12 |
| ACI | 12 |
| CO | 12 |
| Brooklyn | 12 |
| Ahmed | 12 |
| AST | 12 |
| Global | 12 |
| Florida | 12 |
| J | 12 |
| Guidelines | 12 |
| Singapore | 12 |
| sec | 12 |
| meropenem | 12 |
| TnI | 12 |
| III | 12 |
| Social | 12 |
| Statistical | 12 |
| Radiology | 12 |
| NIPPV | 12 |
| Michael | 12 |
| Lopinavir | 12 |
| Fisher | 11 |
| European | 11 |
| ESR | 11 |
| Data | 11 |
| EBRT | 11 |
| Dis | 11 |
| Bernardino | 11 |
| Council | 11 |
| CCS | 11 |
| CA | 11 |
| Arbidol | 11 |
| AIR | 11 |
| IgM | 11 |
| HRCT | 11 |
| Epstein | 11 |
| LV | 11 |
| State | 11 |
| MAT | 11 |
| enoxaparin | 11 |
| doc_id | 11 |
| UNS | 11 |
| Team | 11 |
| cTnI | 11 |
| Respiratory | 11 |
| Report | 11 |
| NL63 | 11 |
| N | 11 |
| • | 11 |
| Muhammad | 11 |
| HCPs | 10 |
| Meta | 10 |
| Medicare | 10 |
| Medicaid | 10 |
| MSSA | 10 |
| Legionella | 10 |
| Kathmandu | 10 |
| Infection | 10 |
| IVIG | 10 |
| Appendix | 10 |
| Guidance | 10 |
| Embase | 10 |
| Directors | 10 |
| Chen | 10 |
| CTA | 10 |
| Barr | 10 |
| North | 10 |
| Americans | 10 |
| ATIII | 10 |
| Moraxella | 10 |
| AOSD | 10 |
| PRISMA | 10 |
| Tregs | 10 |
| PUI | 10 |
| α | 10 |
| series | 10 |
| proBNP | 10 |
| p<0.01 | 10 |
| mL. | 10 |
| WSU | 10 |
| VSD | 10 |
| Wang | 10 |
| Tokyo | 10 |
| Statistics | 10 |
| SJS | 10 |
| Python | 10 |
| Program | 10 |
| Presentation | 10 |
| Personal | 10 |
| Systematic | 10 |
| Patients | 10 |
| General | 9 |
| D3 | 9 |
| EMR | 9 |
| GM | 9 |
| HKU1 | 9 |
| Geographic | 9 |
| Glasgow | 9 |
| Coxsackievirus | 9 |
| Cr | 9 |
| ANA | 9 |
| Cochrane | 9 |
| Christ | 9 |
| Cardiovascular | 9 |
| Cardiac | 9 |
| B4 | 9 |
| B12 | 9 |
| Anosmia | 9 |
| AUC | 9 |
| Khan | 9 |
| Inc. | 9 |
| Malik | 9 |
| Level | 9 |
| R | 9 |
| tPA | 9 |
| ivermectin | 9 |
| arthralgia | 9 |
| Lung | 9 |
| System | 9 |
| Student | 9 |
| Residency | 9 |
| Reporting | 9 |
| TNF | 9 |
| QTc | 9 |
| Province | 9 |
| PTSD | 9 |
| PO | 9 |
| OS | 9 |
| OE | 9 |
| Network | 9 |
| MOF | 9 |
| Pulmonary | 9 |
| Impact | 8 |
| GDP | 8 |
| Group | 8 |
| H | 8 |
| HR | 8 |
| Hamburg | 8 |
| Li | 8 |
| Index | 8 |
| John | 8 |
| LC | 8 |
| NLR | 8 |
| Ethics | 8 |
| First | 8 |
| Netherlands | 8 |
| Epidemiology | 8 |
| Electrocardiogram | 8 |
| Drug | 8 |
| Chloroquine | 8 |
| Cardiology | 8 |
| CME | 8 |
| CMB | 8 |
| BMI | 8 |
| Azithromycin | 8 |
| Agency | 8 |
| Administration | 8 |
| ACGME | 8 |
| 5-Point | 8 |
| NRMP | 8 |
| Regional | 8 |
| Orthopaedic | 8 |
| SEIR | 8 |
| Outcomes | 8 |
| tachypnea | 8 |
| pg | 8 |
| p=0.001 | 8 |
| ms | 8 |
| lymphohistiocytosis | 8 |
| dL | 8 |
| coronavirus-2 | 8 |
| Zhang | 8 |
| 8 | |
| Systems | 8 |
| Stroke | 8 |
| dl | 8 |
| SD | 8 |
| Patel | 8 |
| Response | 8 |
| PNS | 8 |
| PT | 8 |
| PTH | 8 |
| Package | 8 |
| PaO | 8 |
| Pearson | 8 |
| Post | 8 |
| Protection | 8 |
| RALE | 8 |
| ® | 8 |
| Eucharist | 7 |
| Items | 7 |
| Fahrenheit | 7 |
| Government | 7 |
| HF | 7 |
| Huang | 7 |
| IL | 7 |
| Information | 7 |
| Mann | 7 |
| Jesus | 7 |
| Kanagawa | 7 |
| LVEF | 7 |
| Liver | 7 |
| MHRA | 7 |
| Mass | 7 |
| EVALI | 7 |
| Education | 7 |
| Ali | 7 |
| ESC | 7 |
| CHD | 7 |
| AZM | 7 |
| Acetazolamide | 7 |
| NCO | 7 |
| Bangladesh | 7 |
| Barre | 7 |
| Barré | 7 |
| CKD | 7 |
| EDS | 7 |
| Cerebral | 7 |
| CoV. | 7 |
| Coma | 7 |
| Community | 7 |
| Critical | 7 |
| Development | 7 |
| Mental | 7 |
| Iqbal | 7 |
| Nifedipine | 7 |
| doxycycline | 7 |
| Temperature | 7 |
| VTE | 7 |
| Viruses | 7 |
| Windows | 7 |
| Zoom | 7 |
| bronchoalveolar | 7 |
| covid-19 | 7 |
| min | 7 |
| Switzerland | 7 |
| monocyte | 7 |
| oseltamivir | 7 |
| prednisone | 7 |
| thromboplastin | 7 |
| ± | 7 |
| ○ | 7 |
| No | 7 |
| TAC | 7 |
| metformin | 7 |
| Survey | 7 |
| Reviews | 7 |
| Office | 7 |
| Services | 7 |
| Oncology | 7 |
| PCI | 7 |
| PREPRINT | 7 |
| PTE | 7 |
| RCT | 7 |
| PS | 7 |
| Risk | 7 |
| SBC | 7 |
| SWI | 7 |
| Scholar | 7 |
| Seattle | 7 |
| Series | 7 |
| Ddimer | 6 |
| Foundation | 6 |
| HCC | 6 |
| Graduate | 6 |
| G | 6 |
| ECHO | 6 |
| Economic | 6 |
| Database | 6 |
| E | 6 |
| HCW | 6 |
| HCV | 6 |
| IFN | 6 |
| HELLP | 6 |
| HU | 6 |
| Heart | 6 |
| Hopkins | 6 |
| IABP | 6 |
| ICMR | 6 |
| IL-10 | 6 |
| IL-2 | 6 |
| Conclusion | 6 |
| IR | 6 |
| Cryptococcus | 6 |
| ASOD | 6 |
| CoV2 | 6 |
| Chi | 6 |
| Kumar | 6 |
| A1c | 6 |
| ACC | 6 |
| ACTH | 6 |
| AG | 6 |
| ARMC | 6 |
| ASRS | 6 |
| Academy | 6 |
| Act | 6 |
| Analyses | 6 |
| Arab | 6 |
| Background | 6 |
| Bahrain | 6 |
| Beijing | 6 |
| Beirut | 6 |
| Boot | 6 |
| CI | 6 |
| COVID-2019 | 6 |
| CRRT | 6 |
| CRS | 6 |
| CVE | 6 |
| Klebsiella | 6 |
| Software | 6 |
| LLE | 6 |
| cribriform | 6 |
| Version | 6 |
| Vietnam | 6 |
| Washington | 6 |
| 6 | |
| Whitney | 6 |
| Wilcoxon | 6 |
| Workers | 6 |
| Y | 6 |
| chloroquine | 6 |
| committee | 6 |
| elevation | 6 |
| Toronto | 6 |
| hypogeusia | 6 |
| mid | 6 |
| neurology | 6 |
| pH | 6 |
| pancytopenia | 6 |
| pneumocyte | 6 |
| rRT | 6 |
| vs. | 6 |
| Liang | 6 |
| μmol | 6 |
| Transmission | 6 |
| favipiravir | 6 |
| Taxonomy | 6 |
| Population | 6 |
| NK | 6 |
| Narcolepsy | 6 |
| Surgery | 6 |
| Neurological | 6 |
| Neurology | 6 |
| Opioid | 6 |
| P<.01 | 6 |
| PICU | 6 |
| PID | 6 |
| Plan | 6 |
| P | 6 |
| Streptococcus | 6 |
| QD | 6 |
| QT | 6 |
| Ritonavir | 6 |
| Students | 6 |
| Safety | 6 |
| Service | 6 |
| Professor | 6 |
| SpO | 6 |
| Effectiveness | 5 |
| IEC | 5 |
| I | 5 |
| Hussain | 5 |
| HRCP | 5 |
| HCA | 5 |
| Force | 5 |
| Gupta | 5 |
| GGOs | 5 |
| Food | 5 |
| Fleischner | 5 |
| Edema | 5 |
| IL-7 | 5 |
| IL)-6 | 5 |
| MA | 5 |
| INR | 5 |
| IQR | 5 |
| Intensive | 5 |
| Introduction | 5 |
| Ivermectin | 5 |
| Knowledge | 5 |
| Lemierre | 5 |
| Liu | 5 |
| MAP | 5 |
| MICU | 5 |
| Methods | 5 |
| NGOs | 5 |
| Dow | 5 |
| NIH | 5 |
| EMRA | 5 |
| Aquifer | 5 |
| Distress | 5 |
| Director | 5 |
| NT1 | 5 |
| -2 | 5 |
| ABG | 5 |
| ACS | 5 |
| AI | 5 |
| AIP | 5 |
| Accreditation | 5 |
| BID | 5 |
| Bank | 5 |
| Berlin | 5 |
| CAA | 5 |
| CBRN | 5 |
| CCI | 5 |
| CMP | 5 |
| CVM | 5 |
| Canada | 5 |
| Cardiogenic | 5 |
| Centre | 5 |
| Chain | 5 |
| Children | 5 |
| CoVs | 5 |
| Coronaviridae | 5 |
| Coronaviruses | 5 |
| Corp | 5 |
| Cryptococcosis | 5 |
| Day | 5 |
| Diagnosis | 5 |
| NSAIDs | 5 |
| department | 5 |
| ORCHID | 5 |
| fondaparinux | 5 |
| VIII | 5 |
| Vaping | 5 |
| Virus | 5 |
| White | 5 |
| Xu | 5 |
| Yamaguchi | 5 |
| Yang | 5 |
| Youth | 5 |
| acetazolamide | 5 |
| adenocarcinomas | 5 |
| bradycardic | 5 |
| bronchogram | 5 |
| enzyme-2 | 5 |
| gm | 5 |
| Thoracic | 5 |
| infarct | 5 |
| key | 5 |
| meningoencephalitis | 5 |
| metronidazole | 5 |
| microthrombi | 5 |
| ml | 5 |
| neurotropic | 5 |
| scan | 5 |
| steering | 5 |
| thromboelastography | 5 |
| transthoracic | 5 |
| ug | 5 |
| October | 5 |
| Tisdale | 5 |
| stroke | 5 |
| Thomas | 5 |
| RCTs | 5 |
| Organisation | 5 |
| Syed | 5 |
| Oseltamivir | 5 |
| Pneumonia | 5 |
| PoE | 5 |
| Polymerase | 5 |
| Preferred | 5 |
| Preoperative | 5 |
| Punjab | 5 |
| Q3 | 5 |
| R0 | 5 |
| RAAS | 5 |
| RADS | 5 |
| PFO | 5 |
| RDW | 5 |
| Shi | 5 |
| RPE | 5 |
| Superfund | 5 |
| Surgeons | 5 |
| Solutions | 5 |
| SoM | 5 |
| Standard | 5 |
| SOFA | 5 |
| SCO | 5 |
| Ribavirin | 5 |
| Radiographic | 5 |
| Radiation | 5 |
| IMV | 4 |
| IBD | 4 |
| Hypercoagulability | 4 |
| Hugh | 4 |
| High | 4 |
| Hg | 4 |
| Helsinki | 4 |
| HbA1C | 4 |
| Hassan | 4 |
| Handbook | 4 |
| HTN | 4 |
| Greek | 4 |
| HLH-2004 | 4 |
| HLA | 4 |
| HIPAA | 4 |
| HCoV-229E | 4 |
| HBV | 4 |
| Gilead | 4 |
| Gao | 4 |
| GCS | 4 |
| Forum | 4 |
| Fitz | 4 |
| FiO | 4 |
| Illinois | 4 |
| Features | 4 |
| IVDU | 4 |
| Letter | 4 |
| Imaging | 4 |
| Indian | 4 |
| England | 4 |
| Monday | 4 |
| Molecular | 4 |
| Mohammed | 4 |
| Minister | 4 |
| Metropolitan | 4 |
| Medline | 4 |
| Med | 4 |
| May. | 4 |
| MMF | 4 |
| MCP1 | 4 |
| Library | 4 |
| Levene | 4 |
| Learning | 4 |
| Laboratory | 4 |
| LT | 4 |
| LA | 4 |
| Khalid | 4 |
| Keppra | 4 |
| Joseph | 4 |
| Jawad | 4 |
| James | 4 |
| Interventions | 4 |
| Environmental | 4 |
| COVID-19-induced | 4 |
| Emerg | 4 |
| CV | 4 |
| COVID-19-Associated | 4 |
| COV | 4 |
| CML | 4 |
| CFR | 4 |
| CBCT | 4 |
| CAC | 4 |
| Brain | 4 |
| Boca | 4 |
| Binswanger | 4 |
| BiPAP | 4 |
| Belgium | 4 |
| Behavioral | 4 |
| Baricitinib | 4 |
| Australia | 4 |
| Associated | 4 |
| Anteroposterior | 4 |
| Al | 4 |
| Ahmad | 4 |
| Advising | 4 |
| Activities | 4 |
| APACHE | 4 |
| ACE | 4 |
| Myocardial | 4 |
| COVID-19-related | 4 |
| Camp | 4 |
| ETT | 4 |
| Canvas | 4 |
| EMS | 4 |
| EF | 4 |
| E4 | 4 |
| Doppler | 4 |
| Division | 4 |
| District | 4 |
| Diamond | 4 |
| Denmark | 4 |
| De | 4 |
| Dashboard | 4 |
| Dakota | 4 |
| DNR | 4 |
| Cytokine | 4 |
| Curtis | 4 |
| Crisis | 4 |
| Corporation | 4 |
| Coronavirus-2 | 4 |
| Core | 4 |
| Comprehensive | 4 |
| Coagulopathy | 4 |
| CoV-1 | 4 |
| Clinic | 4 |
| Church | 4 |
| Mumbai | 4 |
| Results | 4 |
| NCP | 4 |
| health | 4 |
| disease-2019 | 4 |
| dihydropyridine | 4 |
| dexamethasone | 4 |
| darunavir | 4 |
| coronavirus | 4 |
| cilostazol | 4 |
| cefazolin | 4 |
| bpm | 4 |
| baloxavir | 4 |
| association | 4 |
| antiphospholipid | 4 |
| anterior | 4 |
| angiopathy | 4 |
| X | 4 |
| Women | 4 |
| Wilk | 4 |
| Western | 4 |
| West | 4 |
| Wayne | 4 |
| V | 4 |
| UNHCR | 4 |
| Type | 4 |
| Transthoracic | 4 |
| glycylcycline | 4 |
| hemosiderin | 4 |
| Tomography | 4 |
| leukocytosis | 4 |
| Native | 4 |
| µg | 4 |
| vivo | 4 |
| vertigo | 4 |
| vancomycin | 4 |
| tazobactam | 4 |
| tacrolimus | 4 |
| sternoclavicular | 4 |
| sera | 4 |
| review | 4 |
| pneumomediastinum | 4 |
| p=0.01 | 4 |
| p=0.005 | 4 |
| neuro | 4 |
| n=11 | 4 |
| n=10 | 4 |
| mycophenolate | 4 |
| myalgias | 4 |
| methylprednisolone | 4 |
| mesylate | 4 |
| lymphocytopenia | 4 |
| losartan | 4 |
| lisinopril | 4 |
| Tongji | 4 |
| rhinorrhea | 4 |
| Times | 4 |
| Science | 4 |
| SLOE | 4 |
| SAR | 4 |
| Roche | 4 |
| Revival | 4 |
| Retrospective | 4 |
| β1 | 4 |
| Regulatory | 4 |
| Recommendations | 4 |
| Raton | 4 |
| RV | 4 |
| RSV | 4 |
| RDT | 4 |
| Professional | 4 |
| Probation | 4 |
| Princess | 4 |
| Physicians | 4 |
| People | 4 |
| PVE | 4 |
| Observational | 4 |
| Objective | 4 |
| OR | 4 |
| OECD | 4 |
| Thrombosis | 4 |
| SOC | 4 |
| Orthodox | 4 |
| Scientific | 4 |
| Supply | 4 |
| Thrombocytopenia | 4 |
| Shah | 4 |
| Thailand | 4 |
| Texas | 4 |
| Telehealth | 4 |
| Technology | 4 |
| Task | 4 |
| Tahir | 4 |
| TSH | 4 |
| TIA | 4 |
| Surveillance | 4 |
| Newark | 4 |
| Studies | 4 |
| Splenic | 4 |
| Step | 4 |
| Singh | 4 |
| Sharma | 4 |
| Spearman | 4 |
| Smokeless | 4 |
| Shapiro | 4 |
| StatPearls | 4 |
| Stata | 4 |
| StataCorp | 4 |
| Farheen | 3 |
| 3 | |
| Favipiravir | 3 |
| Feasibility | 3 |
| Findings | 3 |
| Francisco | 3 |
| GCSF | 3 |
| GWTG | 3 |
| HIV-1 | 3 |
| Gulshan | 3 |
| Gy/5 | 3 |
| HDR | 3 |
| F. | 3 |
| Haider | 3 |
| Hammad | 3 |
| Hamza | 3 |
| Head | 3 |
| Hip | 3 |
| Hispanics | 3 |
| Hodgkin | 3 |
| FFR | 3 |
| Eric | 3 |
| Extrapulmonary | 3 |
| EMT | 3 |
| Discussion | 3 |
| Home | 3 |
| Disparities | 3 |
| Duke | 3 |
| E. | 3 |
| E6 | 3 |
| EDCD | 3 |
| ELISA | 3 |
| ESS | 3 |
| Expert | 3 |
| Echocardiogram | 3 |
| Electronic | 3 |
| Emerging | 3 |
| Empiric | 3 |
| English | 3 |
| Enoxaparin | 3 |
| Entrustable | 3 |
| Excel | 3 |
| Electrocardiography | 3 |
| LLC | 3 |
| Huanan | 3 |
| ICUs | 3 |
| Latin | 3 |
| Latino | 3 |
| Lee | 3 |
| Literature | 3 |
| Lombardy | 3 |
| London | 3 |
| Louis | 3 |
| M. | 3 |
| MAE | 3 |
| MEDLINE | 3 |
| Macintosh | 3 |
| Majid | 3 |
| Manual | 3 |
| Match | 3 |
| Matching | 3 |
| Mauritius | 3 |
| Mechanical | 3 |
| MedRxiv | 3 |
| Diabetes | 3 |
| LFTs | 3 |
| LCs | 3 |
| LAD | 3 |
| Initial | 3 |
| IL-1 | 3 |
| IL10 | 3 |
| IMP | 3 |
| IMRT | 3 |
| IP10 | 3 |
| IPC | 3 |
| Infarction | 3 |
| Infective | 3 |
| Initiative | 3 |
| Kulachanya | 3 |
| Instructure | 3 |
| Internship | 3 |
| Iron | 3 |
| Johns | 3 |
| Johnson | 3 |
| Jose | 3 |
| Kiani | 3 |
| Klasen | 3 |
| Diagnostic | 3 |
| Anxiety | 3 |
| Detection | 3 |
| Davies | 3 |
| Adult | 3 |
| Affairs | 3 |
| African | 3 |
| Air | 3 |
| Alan | 3 |
| Alaska | 3 |
| Albarello | 3 |
| Alexandra | 3 |
| Alzheimer | 3 |
| Andrew | 3 |
| Angiotensin | 3 |
| Anthony | 3 |
| Antibodies | 3 |
| Metoprolol | 3 |
| Application | 3 |
| Arch | 3 |
| Arif | 3 |
| Arrowhead | 3 |
| Ashraf | 3 |
| Adam | 3 |
| Action | 3 |
| Access | 3 |
| AASLD | 3 |
| ): | 3 |
| -45 | 3 |
| -6 | 3 |
| -8 | 3 |
| -80 | 3 |
| 2D | 3 |
| A. | 3 |
| A1C | 3 |
| ACR | 3 |
| Academic | 3 |
| AIDS | 3 |
| AIS | 3 |
| AMA | 3 |
| ARB | 3 |
| ASTRO | 3 |
| AZT | 3 |
| Ab | 3 |
| Abuse | 3 |
| Atherogenic | 3 |
| Bacteremia | 3 |
| Basel | 3 |
| Conversations | 3 |
| ClinicalTrials.gov | 3 |
| Cloud | 3 |
| Coalition | 3 |
| Commission | 3 |
| Computed | 3 |
| Consensus | 3 |
| Considerations | 3 |
| Context | 3 |
| Coordination | 3 |
| Classifications | 3 |
| Coronary | 3 |
| Countries | 3 |
| Covid | 3 |
| Criteria | 3 |
| Cross | 3 |
| DQB1 | 3 |
| Daily | 3 |
| David | 3 |
| Clerkship | 3 |
| Classification | 3 |
| Betacoronavirus | 3 |
| COVID19 | 3 |
| Bin | 3 |
| Bloomberg | 3 |
| Bradycardia | 3 |
| Breakthrough | 3 |
| Burden | 3 |
| CMV | 3 |
| COT | 3 |
| COVID-19-positive | 3 |
| CPR | 3 |
| Civil | 3 |
| CTPA | 3 |
| CTS | 3 |
| Camostat | 3 |
| Central | 3 |
| Characteristics | 3 |
| Chicago | 3 |
| Chief | 3 |
| Chung | 3 |
| Mediterranean | 3 |
| B. | 3 |
| Microbiology | 3 |
| corona | 3 |
| XII | 3 |
| Young | 3 |
| Yousaf | 3 |
| Z | 3 |
| Zainab | 3 |
| acyclovir | 3 |
| alanine | 3 |
| amoxicillin | 3 |
| analysis | 3 |
| antihyperglycemic | 3 |
| apixaban | 3 |
| arthroplasty | 3 |
| aspartate | 3 |
| atorvastatin | 3 |
| betacoronavirus | 3 |
| biopsy | 3 |
| board | 3 |
| cefepime | 3 |
| cerebral | 3 |
| Wu | 3 |
| Wagner | 3 |
| WURS | 3 |
| Tigecycline | 3 |
| TEE | 3 |
| Tadalafil | 3 |
| Taha | 3 |
| Takotsubo | 3 |
| Tan | 3 |
| Tang | 3 |
| Telemedicine | 3 |
| Tertiary | 3 |
| Tocilizumab | 3 |
| WA | 3 |
| USMLE | 3 |
| Ullanlinna | 3 |
| Umrah | 3 |
| Union | 3 |
| Utah | 3 |
| Ventricular | 3 |
| Vero | 3 |
| Video | 3 |
| chemoattractant | 3 |
| east | 3 |
| T2DM | 3 |
| empyema | 3 |
| noncoronary | 3 |
| p=0.0036 | 3 |
| p=0.02 | 3 |
| p=0.04 | 3 |
| parainfluenza | 3 |
| perforin | 3 |
| pneumocytes | 3 |
| postinfarct | 3 |
| procalcitonin | 3 |
| rhesus | 3 |
| septa | 3 |
| sildenafil | 3 |
| tele | 3 |
| thrombophilia | 3 |
| uL | 3 |
| ° | 3 |
| ɣ | 3 |
| μg | 3 |
| Microsoft | 3 |
| neutrophilia | 3 |
| neurosurgery | 3 |
| national | 3 |
| jirovecii | 3 |
| fluconazole | 3 |
| glycyrrhizin | 3 |
| groundglass | 3 |
| heparin | 3 |
| hepatitis | 3 |
| hepatosplenomegaly | 3 |
| hydrocortisone | 3 |
| inotropic | 3 |
| lavage | 3 |
| n=6 | 3 |
| lobar | 3 |
| metapneumovirus | 3 |
| metoprolol | 3 |
| mofetil | 3 |
| myocyte | 3 |
| n=15 | 3 |
| n=16 | 3 |
| n=55 | 3 |
| TB | 3 |
| dL. | 3 |
| T2 | 3 |
| ROC | 3 |
| PRESS | 3 |
| PTV | 3 |
| PURE | 3 |
| Parathyroid | 3 |
| Pediatrics | 3 |
| Persistence | 3 |
| Perspect | 3 |
| PowerPoint | 3 |
| Presence | 3 |
| Priyanka | 3 |
| Procalcitonin | 3 |
| Product | 3 |
| Products | 3 |
| Psychiatry | 3 |
| Q | 3 |
| Q2 | 3 |
| Qualtrics | 3 |
| RAS | 3 |
| RLS | 3 |
| PFA | 3 |
| PDSA | 3 |
| PCD | 3 |
| Nehad | 3 |
| Migrant | 3 |
| Symptom | 3 |
| Mir | 3 |
| Monaldi | 3 |
| NAT | 3 |
| NHNT | 3 |
| NT2 | 3 |
| Neck | 3 |
| Non | 3 |
| PA | 3 |
| November | 3 |
| Olympics | 3 |
| Online | 3 |
| Open | 3 |
| Ophthalmology | 3 |
| Organ | 3 |
| Osteomyelitis | 3 |
| Oxford | 3 |
| RNAdependent | 3 |
| PRISMS | 3 |
| Siemens | 3 |
| Saint | 3 |
| Salmonella | 3 |
| Sara | 3 |
| Score | 3 |
| Shabarek | 3 |
| Sheriff | 3 |
| Siddiqui | 3 |
| Sildenafil | 3 |
| Statement | 3 |
| Station | 3 |
| Steven | 3 |
| Storm | 3 |
| Stress | 3 |
| Substance | 3 |
| Supper | 3 |
| Surg | 3 |
| Surgeon | 3 |
| Rahul | 3 |
| Suwanwongse | 3 |
| Syeda | 3 |
| Salman | 3 |
| Sandeep | 3 |
| SUN | 3 |
| Rotterdam | 3 |
| Rating | 3 |
| Razaq | 3 |
| Recovery | 3 |
| Region | 3 |
| Remote | 3 |
| Republic | 3 |
| Resident | 3 |
| Robert | 3 |
| Rose | 3 |
| Richard | 3 |
| Russia | 3 |
| SCAI | 3 |
| SRA | 3 |
| Rutgers | 3 |
| SICU | 3 |
| SNE | 3 |
| SA | 3 |
| S2 | 3 |
| Incubation | 2 |
| Indicators | 2 |
| IPH | 2 |
| Inciardi | 2 |
| Indians | 2 |
| In | 2 |
| Immunosuppression | 2 |
| Immune | 2 |
| Ikegami | 2 |
| IVPB | 2 |
| Janssen | 2 |
| IOIBD | 2 |
| IL8 | 2 |
| IL7 | 2 |
| IL1RA | 2 |
| IGRT | 2 |
| ICP | 2 |
| ICNARC | 2 |
| Hypopituitarism | 2 |
| Influence | 2 |
| Hospitalization | 2 |
| Inflammaging | 2 |
| Jackson | 2 |
| Influenza | 2 |
| Inspiratory | 2 |
| Herman | 2 |
| Jain | 2 |
| JUUL | 2 |
| JOA | 2 |
| JAK | 2 |
| J. | 2 |
| Ivan | 2 |
| Italian | 2 |
| Isolation | 2 |
| Islander | 2 |
| Ishita | 2 |
| Ischemic | 2 |
| Involvement | 2 |
| Intubation | 2 |
| Interpretation | 2 |
| Internal | 2 |
| Interim | 2 |
| Institutes | 2 |
| 2 | |
| Holshue | 2 |
| Fitbit | 2 |
| Henry | 2 |
| Fruit | 2 |
| Gayam | 2 |
| Gautret | 2 |
| Gatherings | 2 |
| Gary | 2 |
| Gandhi | 2 |
| GS-5734 | 2 |
| GRE | 2 |
| GFR | 2 |
| G. | 2 |
| Friday | 2 |
| Hemorrhagic | 2 |
| Framingham | 2 |
| Fractional | 2 |
| Fr | 2 |
| Fluid | 2 |
| Flow | 2 |
| Flint | 2 |
| FitBit | 2 |
| Fateen | 2 |
| Jay | 2 |
| Glycyrrhizin | 2 |
| Godil | 2 |
| Grant | 2 |
| Grants | 2 |
| Hemophagocytic | 2 |
| Hemoglobin | 2 |
| Heidi | 2 |
| Healthy | 2 |
| Hb | 2 |
| Hawaiian | 2 |
| Hardinge | 2 |
| Hansen | 2 |
| HNC | 2 |
| HDL | 2 |
| HD | 2 |
| HCoVs | 2 |
| HBDH | 2 |
| Gy/3 | 2 |
| Guo | 2 |
| Guide | 2 |
| Guan | 2 |
| Gresham | 2 |
| Gregory | 2 |
| Jason | 2 |
| Miller | 2 |
| Jefferson | 2 |
| MIP1A | 2 |
| Major | 2 |
| Mahmood | 2 |
| Madhav | 2 |
| MacDonald | 2 |
| MSE | 2 |
| MRA | 2 |
| MR | 2 |
| MOHFW | 2 |
| MODS | 2 |
| MERA | 2 |
| Manthani | 2 |
| MD | 2 |
| MCA | 2 |
| MB | 2 |
| M.osleonsis | 2 |
| Lupus | 2 |
| Luo | 2 |
| Luke | 2 |
| Lp1 | 2 |
| Lovenox | 2 |
| Manifestations | 2 |
| Mao | 2 |
| Jeffrey | 2 |
| Methicillin | 2 |
| Mohamed | 2 |
| Mohamad | 2 |
| Modi | 2 |
| Mithun | 2 |
| Fang | 2 |
| Midwest | 2 |
| Mian | 2 |
| Mg | 2 |
| Methylphenidate | 2 |
| Memorial | 2 |
| Maria | 2 |
| Mehwish | 2 |
| Medrxiv | 2 |
| Medicines | 2 |
| Medication | 2 |
| MeSH | 2 |
| McDonald | 2 |
| Max | 2 |
| Masks | 2 |
| Mask | 2 |
| Lourdes | 2 |
| Lockdown | 2 |
| Liturgy | 2 |
| Karl | 2 |
| Kitasato | 2 |
| King | 2 |
| Kim | 2 |
| Khullar | 2 |
| Khine | 2 |
| Kettering | 2 |
| Kelly | 2 |
| Keio | 2 |
| Kaushik | 2 |
| Karimi | 2 |
| Literacy | 2 |
| Kamal | 2 |
| KFC | 2 |
| K/µL | 2 |
| K. | 2 |
| Jupyter | 2 |
| Juntendo | 2 |
| Journal | 2 |
| Jonathan | 2 |
| Jin | 2 |
| Kochi | 2 |
| Koirala | 2 |
| Konala | 2 |
| Kulkarni | 2 |
| List | 2 |
| Lin | 2 |
| Lewis | 2 |
| Levophed | 2 |
| Levine | 2 |
| Legion | 2 |
| Lebanese | 2 |
| Last | 2 |
| Language | 2 |
| Lake | 2 |
| Lady | 2 |
| Lactate | 2 |
| Lack | 2 |
| LPM | 2 |
| LP | 2 |
| LDL | 2 |
| LCC | 2 |
| L4 | 2 |
| Kussmaul | 2 |
| Far | 2 |
| Co | 2 |
| Family | 2 |
| BRIDGE | 2 |
| Bhilwara | 2 |
| Bhatta | 2 |
| Beta | 2 |
| Beach | 2 |
| Basic | 2 |
| Based | 2 |
| Bajwa | 2 |
| Babinski | 2 |
| BUN | 2 |
| BNP | 2 |
| Black | 2 |
| BMA | 2 |
| Ayesha | 2 |
| Autopsy | 2 |
| Austria | 2 |
| Athens | 2 |
| Ata | 2 |
| Assistant | 2 |
| Assay | 2 |
| Artery | 2 |
| Biomarkers | 2 |
| Blastomyces | 2 |
| Failure | 2 |
| CPK | 2 |
| Celsius | 2 |
| Catalyst | 2 |
| CardioMEMS | 2 |
| Carcinoma | 2 |
| Cao | 2 |
| Candidal | 2 |
| Campus | 2 |
| CXRs | 2 |
| CSMHSs | 2 |
| CPAP | 2 |
| Bowman | 2 |
| COVID-19-associated | 2 |
| CMS | 2 |
| CIFAR | 2 |
| CD14+CD16 | 2 |
| CCBs | 2 |
| C. | 2 |
| Business | 2 |
| Budapest | 2 |
| Brandon | 2 |
| Argatroban | 2 |
| Area | 2 |
| Arabi | 2 |
| ACD | 2 |
| Abbas | 2 |
| AT1R | 2 |
| ASOS | 2 |
| ASA | 2 |
| APTT | 2 |
| APO | 2 |
| ALP | 2 |
| ADEM)-like | 2 |
| ACEI | 2 |
| ACCORD | 2 |
| Apple | 2 |
| AAMC | 2 |
| AAK1 | 2 |
| 3D | 2 |
| -Reporting | 2 |
| -May | 2 |
| -7 | 2 |
| -44 | 2 |
| -10 | 2 |
| Monitor | 2 |
| Abigail | 2 |
| Abolfazl | 2 |
| Activity | 2 |
| Adapa | 2 |
| Appendices | 2 |
| Appendectomy | 2 |
| Anti | 2 |
| Ann | 2 |
| Animal | 2 |
| Angiography | 2 |
| Ang-2 | 2 |
| Ang-1 | 2 |
| Amlodipine | 2 |
| Ambu | 2 |
| Allergy | 2 |
| Alert | 2 |
| Aisha | 2 |
| Airtraq | 2 |
| Ahmady | 2 |
| Ageusia | 2 |
| Advanced | 2 |
| Adults | 2 |
| Adeel | 2 |
| Changsha | 2 |
| Child | 2 |
| Choudhury | 2 |
| Duong | 2 |
| EPA | 2 |
| EEA | 2 |
| EDTA | 2 |
| ECOG | 2 |
| EC90 | 2 |
| E1V2M3 | 2 |
| Dysregulation | 2 |
| Durer | 2 |
| Dur | 2 |
| Douglas | 2 |
| Diego | 2 |
| Dong | 2 |
| Doctors | 2 |
| Divine | 2 |
| Ditan | 2 |
| Disorders | 2 |
| Disinformation | 2 |
| DisasterLit | 2 |
| Disaster | 2 |
| Dimer | 2 |
| EPIC | 2 |
| EQD2 | 2 |
| ESTRO | 2 |
| EU | 2 |
| Factors | 2 |
| Facilities | 2 |
| Experimentation | 2 |
| Experimental | 2 |
| Exempt | 2 |
| Evidence | 2 |
| Erum | 2 |
| Epidemiological | 2 |
| Environ | 2 |
| Endocarditis | 2 |
| Encephalitis | 2 |
| Emily | 2 |
| Electroencephalography | 2 |
| Efforts | 2 |
| Efficacy | 2 |
| Effects | 2 |
| Effect | 2 |
| Easter | 2 |
| EUA | 2 |
| Difference | 2 |
| Dharavi | 2 |
| Choudry | 2 |
| Colleges | 2 |
| Convention | 2 |
| Conjunctival | 2 |
| Conclusions | 2 |
| Complement | 2 |
| Comparative | 2 |
| Communities | 2 |
| Communication | 2 |
| Comité | 2 |
| Columbia | 2 |
| Collaboration | 2 |
| Dhaka | 2 |
| Colab | 2 |
| Cohort | 2 |
| Coast | 2 |
| CoVZXC21 | 2 |
| CoV-19 | 2 |
| Cloth | 2 |
| Clinicaltrials.gov | 2 |
| Chu | 2 |
| Chrysanthos | 2 |
| Cook | 2 |
| Coronavirus-2019 | 2 |
| Country | 2 |
| Cox | 2 |
| Dexamethasone | 2 |
| Dev | 2 |
| Determination | 2 |
| Detention | 2 |
| Desai | 2 |
| Dermatology | 2 |
| Depression | 2 |
| DenseNet | 2 |
| Death | 2 |
| Daniel | 2 |
| DSM-5 | 2 |
| DASS-21 | 2 |
| Cytomegalovirus | 2 |
| Current | 2 |
| Cup | 2 |
| Crystal | 2 |
| Crohn | 2 |
| Creactive | 2 |
| Coxsackie | 2 |
| Mohammad | 2 |
| Di | 2 |
| Monitoring | 2 |
| Waltham | 2 |
| Zahid | 2 |
| Yu | 2 |
| YOR | 2 |
| Xray | 2 |
| Xiao | 2 |
| Xia | 2 |
| Wisconsin | 2 |
| Willebrand | 2 |
| Watch | 2 |
| Walter | 2 |
| Zhao | 2 |
| WHO-5 | 2 |
| Virchow | 2 |
| Vijay | 2 |
| Venu | 2 |
| Ventilator | 2 |
| Ventilation | 2 |
| Venovenous | 2 |
| Vancomycin | 2 |
| VEGFA | 2 |
| Zaidi | 2 |
| Zheng | 2 |
| coxsackievirus | 2 |
| biventricular | 2 |
| count | 2 |
| corticosteroid | 2 |
| coronaviridae | 2 |
| chi | 2 |
| centrilobular | 2 |
| cardiomyocyte | 2 |
| cardiac | 2 |
| capecitabine | 2 |
| bocavirus | 2 |
| biocidal | 2 |
| Zhongnan | 2 |
| azathioprine | 2 |
| attentiondeficit | 2 |
| arbidol | 2 |
| apo | 2 |
| antithymocyte | 2 |
| anosmia | 2 |
| aVR | 2 |
| aVL | 2 |
| Zhou | 2 |
| Uzma | 2 |
| Uzair | 2 |
| Universitario | 2 |
| Strategies | 2 |
| TNFα | 2 |
| TEG | 2 |
| TAVR | 2 |
| T3 | 2 |
| T2P | 2 |
| Sweden | 2 |
| Susceptible | 2 |
| Sulaiman | 2 |
| Subjects | 2 |
| Staten | 2 |
| Universidad | 2 |
| Staph | 2 |
| St. | 2 |
| Srikanth | 2 |
| Sreedhar | 2 |
| Square | 2 |
| Springer | 2 |
| Spring | 2 |
| Spinalonga | 2 |
| SpO2 | 2 |
| TRx | 2 |
| TTS | 2 |
| Tables | 2 |
| Tamiflu | 2 |
| Unit | 2 |
| Umifenovir | 2 |
| Ulloa | 2 |
| Uganda | 2 |
| UTI | 2 |
| URTI | 2 |
| UA | 2 |
| Troponin | 2 |
| Trial | 2 |
| Transplant | 2 |
| Tobacco | 2 |
| Time | 2 |
| Therapy | 2 |
| Therapeutic | 2 |
| Th2 | 2 |
| Testing | 2 |
| Test | 2 |
| Tcell | 2 |
| Tanaka | 2 |
| covid | 2 |
| cryptogenic | 2 |
| Sohaib | 2 |
| pandemic | 2 |
| protein-1 | 2 |
| pp1b | 2 |
| pp1a | 2 |
| posteroanterior | 2 |
| posterior | 2 |
| portal | 2 |
| pneumophila | 2 |
| pneumonia | 2 |
| papilledema | 2 |
| p>0.05 | 2 |
| radiology | 2 |
| p=0.38 | 2 |
| p=0.013 | 2 |
| p=0.0026 | 2 |
| p<0.001 | 2 |
| oxcarbazepine | 2 |
| ophthalmology | 2 |
| nucleatum | 2 |
| nonsurvivors | 2 |
| naso | 2 |
| pulmonary | 2 |
| random | 2 |
| del | 2 |
| tadalafil | 2 |
| Monk | 2 |
| −1 | 2 |
| μM | 2 |
| © | 2 |
| world | 2 |
| von | 2 |
| veno | 2 |
| umol | 2 |
| thrombophlebitis | 2 |
| study | 2 |
| ray | 2 |
| stereotactic | 2 |
| simplex | 2 |
| sellar | 2 |
| sciences | 2 |
| sars | 2 |
| sHLH | 2 |
| rt | 2 |
| rhonchi | 2 |
| research | 2 |
| narcolepsy | 2 |
| n=32 | 2 |
| n=30 | 2 |
| hyperimmune | 2 |
| intralobular | 2 |
| interventricular | 2 |
| interlobular | 2 |
| interferongamma | 2 |
| inhospital | 2 |
| idiogenic | 2 |
| hypertensives | 2 |
| hyperosmolar | 2 |
| hyperinflammatory | 2 |
| hypercoagulability | 2 |
| n=23 | 2 |
| 2 | |
| globulins | 2 |
| glipizide | 2 |
| gemcitabine | 2 |
| fL | 2 |
| excel | 2 |
| epileptiform | 2 |
| enoxaprin | 2 |
| disease-19 | 2 |
| intraparenchymal | 2 |
| irbesartan | 2 |
| joint | 2 |
| kb | 2 |
| n=20 | 2 |
| n=101 | 2 |
| n= | 2 |
| myelitis | 2 |
| multilobe | 2 |
| mucositis | 2 |
| mmHg | 2 |
| ministry | 2 |
| middle | 2 |
| microangiopathy | 2 |
| methotrexate | 2 |
| mental | 2 |
| mean±SD | 2 |
| mcg | 2 |
| lipoprotein | 2 |
| linezolid | 2 |
| legionella | 2 |
| lacunar | 2 |
| lacosamide | 2 |
| Somali | 2 |
| hypofractionated | 2 |
| Soe | 2 |
| PRO | 2 |
| Pathological | 2 |
| Pata | 2 |
| Passerini | 2 |
| Panel | 2 |
| Pan | 2 |
| Palm | 2 |
| Pakistani | 2 |
| PaCO2 | 2 |
| PTT | 2 |
| PPMPs | 2 |
| Pavia | 2 |
| PPEs | 2 |
| PEEP | 2 |
| PDGFB | 2 |
| PCO2 | 2 |
| PCO | 2 |
| P. | 2 |
| Ovid | 2 |
| Overview | 2 |
| Outbreak | 2 |
| Paul | 2 |
| Pediatr | 2 |
| Prognostic | 2 |
| Plasma | 2 |
| Principles | 2 |
| Prime | 2 |
| Presentations | 2 |
| Predictors | 2 |
| Prediction | 2 |
| Practical | 2 |
| Power | 2 |
| Positive | 2 |
| Pooja | 2 |
| Philip | 2 |
| Pediatric | 2 |
| Pharmacologic | 2 |
| Pharma | 2 |
| PhD | 2 |
| Pfau | 2 |
| Perspectives | 2 |
| Perspective | 2 |
| Percutaneous | 2 |
| Perceptions | 2 |
| Pennsylvania | 2 |
| Otolaryngol | 2 |
| Orleans | 2 |
| Oral | 2 |
| NAC | 2 |
| NPHL | 2 |
| NJ | 2 |
| NIAID | 2 |
| NHS | 2 |
| NECO | 2 |
| NCT04407572 | 2 |
| NCE | 2 |
| NCBI | 2 |
| NAS | 2 |
| Myanmar | 2 |
| Options | 2 |
| Murthy | 2 |
| Murray | 2 |
| Muddasir | 2 |
| Ms. | 2 |
| Most | 2 |
| Mosaic | 2 |
| Sloan | 2 |
| Moran | 2 |
| Mortality | 2 |
| NPIs | 2 |
| NPO | 2 |
| NRBM | 2 |
| NSTEMI | 2 |
| Oncodisc | 2 |
| Ohno | 2 |
| Occupational | 2 |
| OSNs | 2 |
| Nyein | 2 |
| Nurses | 2 |
| Nsp15 | 2 |
| Northfield | 2 |
| Norte | 2 |
| Nikon | 2 |
| Nikolaos | 2 |
| Nepali | 2 |
| Neeki | 2 |
| Natl | 2 |
| Nations | 2 |
| Naramala | 2 |
| Napoli | 2 |
| Nanjing | 2 |
| NYC | 2 |
| Professionals | 2 |
| Objectives | 2 |
| Proning | 2 |
| STAR | 2 |
| Sanchez | 2 |
| Sample | 2 |
| Salt | 2 |
| Salem | 2 |
| Salazar | 2 |
| Sajed | 2 |
| SaO | 2 |
| STIs | 2 |
| STD | 2 |
| SQ | 2 |
| Sars | 2 |
| SIMPRO | 2 |
| SHOCK | 2 |
| SARS- | 2 |
| SAH | 2 |
| S3 | 2 |
| S1 | 2 |
| S. | 2 |
| S(I | 2 |
| Ruth | 2 |
| Sarbecovirus | 2 |
| Secondary | 2 |
| Rosuvastatin | 2 |
| Sherif | 2 |
| Sjögren | 2 |
| Sleep | 2 |
| Simulation | 2 |
| Propofol | 2 |
| Silver | 2 |
| Silva | 2 |
| Shortages | 2 |
| Shock | 2 |
| Shizuoka | 2 |
| Shen | 2 |
| Sectional | 2 |
| Sheharyar | 2 |
| Shanghai | 2 |
| Shan | 2 |
| Severe | 2 |
| Serum | 2 |
| Sequential | 2 |
| September | 2 |
| Semmelweis | 2 |
| Self | 2 |
| Roudabeh | 2 |
| Scotland | 2 |
| Rossi | 2 |
| Quebec | 2 |
| Randomized | 2 |
| Racial | 2 |
| RTOG | 2 |
| RTC | 2 |
| RNAemia | 2 |
| RNAaemia | 2 |
| RDV | 2 |
| RCP | 2 |
| RA | 2 |
| Quality | 2 |
| Rasheed | 2 |
| Qtc | 2 |
| Qian | 2 |
| Q(III | 2 |
| Publishing | 2 |
| Psychiatric | 2 |
| Providers | 2 |
| Protein | 2 |
| Providence | 2 |
| Prototype | 2 |
| RaoSoft | 2 |
| RBC | 2 |
| Rasmussen | 2 |
| Rehman | 2 |
| Respir | 2 |
| Respirators | 2 |
| Rico | 2 |
| Rikinkumar | 2 |
| Resources | 2 |
| Resource | 2 |
| Reserve | 2 |
| Renmin | 2 |
| Renal | 2 |
| Res | 2 |
| Rawalpindi | 2 |
| RdRp | 2 |
| Refugee | 2 |
| Reduction | 2 |
| Reddy | 2 |
| Real | 2 |
| Registry | 2 |
| Reactive | 2 |
| Hypovitaminosis | 1 |
| Hypofractionated | 1 |
| Hypertriglyceridemia | 1 |
| Hyperviscosity | 1 |
| Hyposomnia | 1 |
| Hyponatremia | 1 |
| Hypoplasia | 1 |
| Hypotheses | 1 |
| Hyperinsulinemia | 1 |
| Hypovolemic | 1 |
| Hyperintensity | 1 |
| Hussaini | 1 |
| Hyperglycemic | 1 |
| Hyperferritinemia | 1 |
| Hyperferritinaemia | 1 |
| Hygiene | 1 |
| Huutoniemi | 1 |
| Hussein | 1 |
| Humalog | 1 |
| Hurst | 1 |
| Huq | 1 |
| Hungary | 1 |
| Hum | 1 |
| ICAM-1 | 1 |
| Humectants | 1 |
| IBV | 1 |
| ILR | 1 |
| ICD | 1 |
| IL1b | 1 |
| IPF | 1 |
| Hui | 1 |
| ISRN | 1 |
| IP | 1 |
| INFγ | 1 |
| INF | 1 |
| ILinhibitors | 1 |
| IL]-6 | 1 |
| IREF | 1 |
| ILD | 1 |
| IL2 | 1 |
| IL-33 | 1 |
| ICSD | 1 |
| IL-18 | 1 |
| IL-17 | 1 |
| IL-12 | 1 |
| IL)-2 | 1 |
| IL)-1 | 1 |
| IIA | 1 |
| IEOCC | 1 |
| IDSA | 1 |
| IDH | 1 |
| ID | 1 |
| ICTV | 1 |
| Hultman | 1 |
| Help'-Why | 1 |
| Huet | 1 |
| Hubbs | 1 |
| Highresolution | 1 |
| Heyl | 1 |
| Herpes | 1 |
| Herald | 1 |
| Hepatitis | 1 |
| Heparininduced | 1 |
| Hendrik | 1 |
| Hendifar | 1 |
| Hemostasis | 1 |
| Hemophagocytosis | 1 |
| Hemodynamic | 1 |
| Hemmens | 1 |
| Hematology | 1 |
| Hebei | 1 |
| Hearing | 1 |
| HbA1c | 1 |
| HbA | 1 |
| HazMat | 1 |
| Hawaii | 1 |
| Haven | 1 |
| Hasnain | 1 |
| Hashimoto | 1 |
| ITP | 1 |
| Hart | 1 |
| Harvard | 1 |
| Highrisk | 1 |
| Hillman | 1 |
| Hina | 1 |
| Hobbs | 1 |
| Hub | 1 |
| Hu | 1 |
| Htun | 1 |
| Houston | 1 |
| Hospitals | 1 |
| Hospitalized | 1 |
| Hoshmand | 1 |
| Honduras | 1 |
| Hoilat | 1 |
| Hoffmann | 1 |
| Hoffman | 1 |
| Hoang | 1 |
| Hindi | 1 |
| Hnin | 1 |
| Hlaing | 1 |
| Histopathology | 1 |
| Histologic | 1 |
| Hispanic | 1 |
| Hiroshima | 1 |
| Hiroki | 1 |
| Hira | 1 |
| Hippocrates | 1 |
| Hint | 1 |
| Hindu | 1 |
| ISTH | 1 |
| Jais | 1 |
| IUSS | 1 |
| Intern | 1 |
| JS | 1 |
| JPN | 1 |
| JP | 1 |
| JIKI | 1 |
| JIA | 1 |
| JACC | 1 |
| Ivana | 1 |
| Ismail | 1 |
| Islands | 1 |
| Islam | 1 |
| Isil | 1 |
| Ishraquzzaman | 1 |
| Ishaq | 1 |
| Ischemia | 1 |
| Isaac | 1 |
| Iqra | 1 |
| Iowa | 1 |
| Ions | 1 |
| Investigating | 1 |
| Invasive | 1 |
| Intraaortic | 1 |
| Intl | 1 |
| Interventional | 1 |
| Intervention | 1 |
| Interns | 1 |
| JUPITER | 1 |
| JVP | 1 |
| Jacob | 1 |
| Janus | 1 |
| Jean | 1 |
| Harshavardhan | 1 |
| Jayson | 1 |
| Jawwad | 1 |
| Javaid | 1 |
| Jasndeep | 1 |
| Jasmin | 1 |
| Jarou | 1 |
| Jarl | 1 |
| Japanese | 1 |
| Jaoude | 1 |
| Janeway | 1 |
| Jacqueline | 1 |
| Jane | 1 |
| Janata | 1 |
| Janak | 1 |
| Jan | 1 |
| Jamshed | 1 |
| Jamil | 1 |
| Jameel | 1 |
| Jamaat | 1 |
| Jahanzeb | 1 |
| Jagdesh | 1 |
| Jadeja | 1 |
| Internetbased | 1 |
| Intermountain | 1 |
| IVA | 1 |
| Interleukin-2 | 1 |
| Implementation | 1 |
| Imperial | 1 |
| Immunotherapy | 1 |
| Immunology | 1 |
| Immunohematologic | 1 |
| Immunogenicity | 1 |
| Immunodeficiency | 1 |
| Immunocompromised | 1 |
| Immunocompetent | 1 |
| Immunoassay | 1 |
| Immigration | 1 |
| Images | 1 |
| Ilyas | 1 |
| Iltaf | 1 |
| Illness | 1 |
| Ill | 1 |
| Ilie | 1 |
| Ignatius | 1 |
| Ig | 1 |
| Idaho | 1 |
| Ibuprofen | 1 |
| Ibsens | 1 |
| Ian | 1 |
| IX | 1 |
| IVC | 1 |
| Import | 1 |
| Importance | 1 |
| Improved | 1 |
| InfoAmazonia | 1 |
| Interleukin | 1 |
| Intergroup | 1 |
| Interfaith | 1 |
| Insurance | 1 |
| Insulin | 1 |
| Instruments | 1 |
| Inst | 1 |
| Inoue | 1 |
| Inland | 1 |
| Inkbird | 1 |
| Injury | 1 |
| Infektionsgefährdung | 1 |
| Improvement | 1 |
| Infected | 1 |
| Infect | 1 |
| Infarctions | 1 |
| Infant | 1 |
| Industries | 1 |
| Induction | 1 |
| Indoor | 1 |
| Independent | 1 |
| Incidental | 1 |
| Incidence | 1 |
| Imran | 1 |
| Harshit | 1 |
| Fleiss | 1 |
| Harpreet | 1 |
| Francesca | 1 |
| GYN | 1 |
| GTV | 1 |
| GS5734 | 1 |
| GS-441524 | 1 |
| GPS | 1 |
| GMCSF | 1 |
| GGN | 1 |
| GEMO | 1 |
| GAR-936 | 1 |
| GAD-7 | 1 |
| G*Power | 1 |
| G)- | 1 |
| F˚ | 1 |
| Future | 1 |
| Full | 1 |
| Fukushima | 1 |
| Front | 1 |
| Freedom | 1 |
| Frederic | 1 |
| François | 1 |
| Fransawy | 1 |
| Franklin | 1 |
| Frankfurt | 1 |
| Frankel | 1 |
| Francis | 1 |
| Gaballa | 1 |
| Gabapentin | 1 |
| Gabriel | 1 |
| Gay | 1 |
| GeneXpert | 1 |
| Gene | 1 |
| Gender | 1 |
| GenBank | 1 |
| Gen | 1 |
| Gelovani | 1 |
| Gefahr | 1 |
| Geevarghese | 1 |
| Gazzaz | 1 |
| Gaziano | 1 |
| Gaynier | 1 |
| Gavin | 1 |
| Gail | 1 |
| Gautier | 1 |
| Gaur | 1 |
| Gaunkar | 1 |
| Gasperino | 1 |
| Gaspar | 1 |
| Gasior | 1 |
| Gash | 1 |
| Garron | 1 |
| Gap | 1 |
| Gane | 1 |
| Gamaletsou | 1 |
| Franceschi | 1 |
| Framework | 1 |
| Harm | 1 |
| Fourth | 1 |
| Feedforward | 1 |
| Feedback | 1 |
| Federal | 1 |
| Feder | 1 |
| Fed | 1 |
| Fears | 1 |
| Fazila | 1 |
| Fawzi | 1 |
| Fatima | 1 |
| Father | 1 |
| Fast | 1 |
| Faryal | 1 |
| Farooque | 1 |
| Farooq | 1 |
| Farha | 1 |
| Fares | 1 |
| Farahmandian | 1 |
| Farah | 1 |
| Fanglong | 1 |
| Faller | 1 |
| Falco | 1 |
| Faith | 1 |
| Faine | 1 |
| Factor | 1 |
| Facilitator | 1 |
| Ferguson | 1 |
| Ferro | 1 |
| Fibrinoid | 1 |
| Flory | 1 |
| Four | 1 |
| Fount | 1 |
| Foster | 1 |
| Forward | 1 |
| Forte | 1 |
| Forms | 1 |
| Foreign | 1 |
| Foramen | 1 |
| Fontana | 1 |
| Fondaparinux | 1 |
| Focus | 1 |
| Flores | 1 |
| Fiedler | 1 |
| Flexner | 1 |
| Jeremy | 1 |
| Flatbush | 1 |
| Five | 1 |
| Fischer | 1 |
| Fio2 | 1 |
| Finska | 1 |
| Filip | 1 |
| Filatov | 1 |
| Fifth | 1 |
| Fifteen | 1 |
| Genome | 1 |
| Genomic | 1 |
| Genuit | 1 |
| Geographer | 1 |
| HR=1.06 | 1 |
| HR2 | 1 |
| HR1 | 1 |
| HR/2020/44/2R. | 1 |
| HPV | 1 |
| HPO-23WH | 1 |
| HOPE | 1 |
| HMPCMCE/ | 1 |
| HM | 1 |
| HLH-94 | 1 |
| HL | 1 |
| HKU | 1 |
| HIVpositive | 1 |
| HIDA | 1 |
| HEPA | 1 |
| HEF | 1 |
| HEENT | 1 |
| HDPs | 1 |
| HCoV)-229E | 1 |
| HCO | 1 |
| HCG | 1 |
| HBsAg | 1 |
| HAART | 1 |
| H2O. | 1 |
| H1N1pdm2009 | 1 |
| HRD | 1 |
| HRH | 1 |
| HSE | 1 |
| Hallo | 1 |
| Harini | 1 |
| Hari | 1 |
| Hardik | 1 |
| Haowei | 1 |
| Hanoi | 1 |
| Hanif | 1 |
| Hani | 1 |
| Hand | 1 |
| Han | 1 |
| Hampshire | 1 |
| Hambrecht | 1 |
| Hajj | 1 |
| HScore | 1 |
| Haifang | 1 |
| Hage | 1 |
| Hafiz | 1 |
| Haemostasis | 1 |
| Haemophagocytic | 1 |
| Haematopoietic | 1 |
| Habitués | 1 |
| Habitat | 1 |
| H^2 | 1 |
| HUN | 1 |
| HTPLC | 1 |
| H&SS | 1 |
| Gy/9 | 1 |
| Gy/15 | 1 |
| Glass | 1 |
| Goldner | 1 |
| Goff | 1 |
| Goel | 1 |
| God | 1 |